{
    "Trade/Device Name(s)": [
        "ARCHITECT HSV-1 IgG",
        "ARCHITECT HSV-1 IgG Calibrator",
        "ARCHITECT HSV-1 IgG Controls"
    ],
    "Submitter Information": "Biokit, S.A.",
    "510(k) Number": "K213987",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ"
    ],
    "Summary Letter Date": "April 5, 2023",
    "Summary Letter Received Date": "April 7, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Serological Assays"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgG antibodies to herpes simplex virus type 1 (HSV-1)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Dipotassium EDTA tube",
        "Lithium heparin tube",
        "Lithium heparin plasma separator tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System",
        "ARCHITECT i2000SR"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT HSV-1 IgG assay using CMIA for qualitative detection of HSV-1 IgG antibodies in serum and plasma",
    "Indications for Use Summary": "Aids in presumptive diagnosis of HSV-1 infection in sexually active adults or expectant mothers by qualitative detection of specific IgG antibodies in human serum and plasma on the ARCHITECT i System",
    "fda_folder": "Microbiology"
}